Back
Relmada Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
RLMD
Relmada Therapeutics
Last Price:
$0.37
Seasonality Move:
8.98%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
Relmada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 2.53 | Sell |
| 200-day SMA: | 3.35 | Sell |
| 8-day EMA: | 0.47 | Sell |
| 20-day EMA: | 1.12 | Sell |
| 50-day EMA: | 2.06 | Sell |
| 200-day EMA: | 3.13 | Sell |
Relmada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 17.01 | Sell |
| Chaikin Money Flow: | 36672 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 2.86) | Sell |
| Bollinger Bands (100): | (1.8 - 3.76) | Sell |
Relmada Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics Stock
Is Relmada Therapeutics Stock a Buy?
-
Relmada Therapeutics share price is 0.36 while RLMD 8-day simple moving average is 0.37, which is a Sell signal.
-
The stock price of RLMD is 0.36 while Relmada Therapeutics 20-day SMA is 1.29, which makes it a Sell.
-
Relmada Therapeutics 50-day simple moving average is 2.53 while RLMD share price is 0.36, making it a Sell technically.
-
RLMD stock price is 0.36 and Relmada Therapeutics 200-day simple moving average is 3.35, creating a Sell signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
27
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy or a Sell?
-
Relmada Therapeutics stock is rated a SellThe current Relmada Therapeutics [RLMD] share price is $0.36. The Score for RLMD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics Stock Info
Market Cap:
11M
Price in USD:
0.36
Share Volume:
424K
Relmada Therapeutics 52-Week Range
52-Week High:
7.22
52-Week Low:
0.34
Sell
27
Relmada Therapeutics (RLMD)
is a Sell
Relmada Therapeutics Share Price Forecast
-
What is the Relmada Therapeutics stock price today?The Relmada Therapeutics stock price is 0.36 USD today.
-
Will RLMD stock go up or go down?Relmada Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Relmada Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics is overvalued.
Is Relmada Therapeutics Stock a Buy?
-
Relmada Therapeutics share price is 0.36 while RLMD 8-day exponential moving average is 0.47, which is a Sell signal.
-
The stock price of RLMD is 0.36 while Relmada Therapeutics 20-day EMA is 1.12, which makes it a Sell.
-
Relmada Therapeutics 50-day exponential moving average is 2.06 while RLMD share price is 0.36, making it a Sell technically.
-
RLMD stock price is 0.36 and Relmada Therapeutics 200-day simple moving average is 3.13, creating a Sell signal.
Fundamental Analysis of Relmada Therapeutics
Is Relmada Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.41 per share.
Technical Analysis of Relmada Therapeutics
Should I short Relmada Therapeutics stock?
-
RLMD Moving Average Covergence Divergence (MACD) indicator is -0.71, suggesting Relmada Therapeutics is a Sell
-
Relmada Therapeutics Relative Strength Index (RSI) is 17.01, which suggest Relmada Therapeutics is oversold
-
The Bollinger Bands (25) for Relmada Therapeutics is (0.36 - 2.86), which suggest Relmada Therapeutics is a Sell
-
The Bollinger Bands (100) for Relmada Therapeutics is (1.8 - 3.76), which suggest Relmada Therapeutics is a Sell
* Relmada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.